tiprankstipranks
Trending News
More News >
Pharma Bio Services (PBSV)
OTHER OTC:PBSV
US Market

Pharma Bio Services (PBSV) Ratios

Compare
45 Followers

Pharma Bio Services Ratios

PBSV's free cash flow for Q1 2026 was $0.31. For the 2026 fiscal year, PBSV's free cash flow was decreased by $ and operating cash flow was
gt;-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Oct 25Oct 24Oct 23Oct 22
Liquidity Ratios
Current Ratio
4.03 7.70 8.32 9.01 9.46
Quick Ratio
4.03 7.70 8.32 9.01 9.46
Cash Ratio
1.74 1.94 3.59 4.85 6.86
Solvency Ratio
<0.01 0.07 -0.23 0.40 0.26
Operating Cash Flow Ratio
-0.05 -0.12 -0.30 0.88 0.28
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 10.01B$ 11.65M$ 13.12M$ 15.63M$ 15.85M
Leverage Ratios
Debt-to-Assets Ratio
0.00 <0.01 0.01 0.02 0.02
Debt-to-Equity Ratio
0.00 <0.01 0.01 0.02 0.03
Debt-to-Capital Ratio
0.00 <0.01 0.01 0.02 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.32 1.15 1.19 1.23 1.25
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.00 <0.01 <0.01 0.02 0.02
Net Debt to EBITDA
60.80 -24.85 5.94 -7.70 -11.40
Profitability Margins
Gross Profit Margin
30.46%32.33%26.46%29.84%25.16%
EBIT Margin
-0.01%-1.05%-13.54%6.58%6.06%
EBITDA Margin
-2.22%1.50%-11.64%7.73%6.32%
Operating Profit Margin
-9.59%-7.08%-13.54%6.58%6.06%
Pretax Profit Margin
-4.05%-1.05%-7.94%9.94%6.13%
Net Profit Margin
0.77%-1.12%-8.18%7.72%5.19%
Continuous Operations Profit Margin
-4.13%-1.12%-8.18%7.72%5.19%
Net Income Per EBT
-18.99%106.58%102.93%77.64%84.71%
EBT Per EBIT
42.20%14.78%58.67%151.02%101.14%
Return on Assets (ROA)
0.24%-0.74%-4.77%6.58%4.87%
Return on Equity (ROE)
0.59%-0.84%-5.67%8.12%6.08%
Return on Capital Employed (ROCE)
-3.99%-5.35%-8.94%6.30%6.34%
Return on Invested Capital (ROIC)
-3.99%-5.34%-8.84%4.85%5.33%
Return on Tangible Assets
0.24%-0.74%-4.77%6.58%4.87%
Earnings Yield
297.88%-0.81%-5.84%6.71%5.09%
Efficiency Ratios
Receivables Turnover
1.61K 3.81 3.79 4.31 3.89
Payables Turnover
3.41K 6.15 6.20 8.12 8.91
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
41.12 61.89 25.85 43.61 33.66
Asset Turnover
0.31 0.66 0.58 0.85 0.94
Working Capital Turnover Ratio
0.85 0.71 0.61 0.97 1.02
Cash Conversion Cycle
0.12 36.33 37.52 39.76 52.78
Days of Sales Outstanding
0.23 95.73 96.38 84.73 93.75
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.11 59.39 58.86 44.97 40.97
Operating Cycle
0.23 95.73 96.38 84.73 93.75
Cash Flow Ratios
Operating Cash Flow Per Share
-6.71 >-0.01 -0.02 0.08 0.03
Free Cash Flow Per Share
-6.71 >-0.01 -0.03 0.08 0.02
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.03 1.28 1.00 0.97
Dividend Paid and CapEx Coverage Ratio
-0.09 -0.12 -0.30 1.09 0.17
Capital Expenditure Coverage Ratio
-21.89K -32.34 -3.55 260.79 30.75
Operating Cash Flow Coverage Ratio
0.00 -7.45 -2.92 5.46 1.22
Operating Cash Flow to Sales Ratio
-0.04 -0.02 -0.06 0.11 0.03
Free Cash Flow Yield
-1396.65%-1.79%-5.45%9.65%2.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
0.34 -123.34 -17.13 14.90 19.65
Price-to-Sales (P/S) Ratio
<0.01 1.38 1.40 1.15 1.02
Price-to-Book (P/B) Ratio
<0.01 1.04 0.97 1.21 1.19
Price-to-Free Cash Flow (P/FCF) Ratio
-0.07 -55.94 -18.34 10.36 34.51
Price-to-Operating Cash Flow Ratio
-0.07 -57.67 -23.50 10.32 33.39
Price-to-Earnings Growth (PEG) Ratio
>-0.01 1.42 0.11 0.49 -0.13
Price-to-Fair Value
<0.01 1.04 0.97 1.21 1.19
Enterprise Value Multiple
60.68 67.06 -6.10 7.18 4.74
Enterprise Value
-5.75B 9.04M 6.75M 9.42M 5.81M
EV to EBITDA
60.68 67.06 -6.10 7.18 4.74
EV to Sales
-1.35 1.00 0.71 0.55 0.30
EV to Free Cash Flow
37.44 -40.81 -9.29 5.00 10.13
EV to Operating Cash Flow
37.44 -42.07 -11.91 4.98 9.80
Tangible Book Value Per Share
446.99 0.52 0.60 0.70 0.72
Shareholders’ Equity Per Share
446.99 0.52 0.60 0.70 0.72
Tax and Other Ratios
Effective Tax Rate
-0.02 -0.07 -0.03 0.22 0.15
Revenue Per Share
186.09 0.39 0.41 0.74 0.84
Net Income Per Share
1.43 >-0.01 -0.03 0.06 0.04
Tax Burden
-0.19 1.07 1.03 0.78 0.85
Interest Burden
322.21 1.00 0.59 1.51 1.01
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
0.90 2.14 0.73 1.44 0.59
Currency in USD